DIA, Chicago 2017

23rd Jun 2017

Richmond Pharmacology is a frequent contributor and recognised thought leader for various scientific meetings worldwide. See below for updated list of upcoming events. DIA

Richmond Pharmacology’s New London Bridge unit offers unrivalled access to patient recruitment

28th Apr 2017

Richmond Pharmacology has been settling into life in its New London Bridge Research Unit.

New CRO unit facility welcomes first overnight patients

31st Mar 2017

Richmond Pharmacology has been busy settling in their first patients at the new London Bridge site.

Richmond Pharmacology Opens New London Bridge Site

03rd Mar 2017

This decision marks the next step in Richmond Pharmacology’s continued growth, having already conducted over 300 studies in London since 2001, often in rare disease areas such

Accelerated Early Phase Drug Development in the UK and Europe

11th Nov 2016

Hear the latest updates about how early phase studies can be accelerated globally by starting first in human trials in the UK then rapidly progress into Europe. This will give

Inotrem successfully completes its first phase I clinical trial with Motrem™, a TREM-1 pathway modulator for the treatment of septic shock

21st Sep 2016

Paris, France, September 13, 2016

Futura Medical plc announce headline results from its efficacy study of the Company’s novel gel for the treatment of erectile dysfunction

21st Sep 2016

Access 500 million patients. Regulators, sponsors….

23rd Mar 2016

Organised by the British Consulate Boston; The Medicines and Healthcare products Regulatory Agency (MHRA), sponsors and investigators came together...

No Triumph Without Trials: The Fight Against Cancer

24th Feb 2016

In the last 70 years, the development of clinical cancer research has been remarkable.

Click here to view our full news archive

Testimonials

I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.

- Anonymous

Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.

- Anonymous

Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.

- Anonymous

Latest news

DIA, Chicago 2017

23rd Jun 2017

Richmond Pharmacology is a frequent contributor and recognised thought leader for various scientific meetings

Read more ›

Richmond Pharmacology’s New London Bridge unit offers unrivalled access to patient recruitment

28th Apr 2017

Richmond Pharmacology has been settling into life in its New London Bridge Research Unit.

Read more ›

New CRO unit facility welcomes first overnight patients

31st Mar 2017

Richmond Pharmacology has been busy settling in their first patients at the new London Bridge site.

Read more ›

American Society for Clinical Pharmacology and Therapeutics (ASCPT)

Mar 15th 2017 | Washington, D.C

Richmond Pharmacology is attending the American Society for Clinical Pharmacology and Therapeutics (ASCPT) event in Washington DC over the next few days.

View all events ›